Potentielle verlaufsmodifizierende Effekte von Lixisenatid in der Frühphase der Parkinsonkrankheit
Crossref DOI link: https://doi.org/10.1007/s42451-024-00681-0
Published Online: 2024-08-02
Published Print: 2024-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Weber, S.
Text and Data Mining valid from 2024-08-02
Version of Record valid from 2024-08-02
Article History
Accepted: 4 July 2024
First Online: 2 August 2024